12.43% -0.2298

Predictive Oncology Inc (POAI)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Predictive Oncology Inc Stock (POAI) Company Profile

Predictive Oncology Inc

Healthcare (1165)

412-432-1500

91 43RD STREET, PITTSBURGH, MN

Nächster Verdiensttermin

Neueste SEC-Einreichungen

POAI's Discussions on Twitter

Vergleichen Sie POAI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
POAI Predictive Oncology Inc	1.46	8.04M	1.52M	-13.97M	-13.29M	-3.05
ISRG Intuitive Surgical Inc	515.36	182.21B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	229.66	66.11B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	91.45	45.01B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	224.02	32.73B	4.93B	1.25B	1.38B	8.47
WST West Pharmaceutical Services Inc	225.08	16.82B	2.88B	499.60M	321.60M	6.74

Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-19	Eingeleitet	H.C. Wainwright	Buy

Predictive Oncology Inc Aktie (POAI) Neueste Nachrichten

Finanzdaten der Predictive Oncology Inc-Aktie (POAI)

Predictive Oncology Inc (POAI)

Predictive Oncology Inc Stock (POAI) Company Profile

Vergleichen Sie POAI mit anderen Aktien

Predictive Oncology Inc Stock (POAI) Upgrades & Downgrades

Predictive Oncology Inc Aktie (POAI) Neueste Nachrichten

Predictive Oncology developed predictive models from 21 compounds from NPDC - TipRanks

Predictive Oncology Successfully Develops Predictive Models - GlobeNewswire

Predictive Oncology (POAI) Stock Surges Following Major Drug Discovery Breakthrough - Stocks Telegraph

Predictive Oncology Develops Advanced Predictive Models for Natural Compounds in Cancer Drug Discovery - Nasdaq

Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary - GlobeNewswire

Revolutionary AI Platform Discovers Superior Cancer Treatments in Record Time - StockTitan

Milestone Merger Payment with Predictive Oncology to Advance AI - newschannelnebraska.com

Predictive Oncology Sells Skyline Medical Assets To DeRoyal Industries - Nasdaq

Predictive Oncology Sells Skyline Medical Assets to DeRoyal Industries - citybiz

Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries to Focus on AI-Driven Drug Discovery - Nasdaq

Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries - GlobeNewswire

Strategic Pivot: Predictive Oncology Divests Medical Assets for AI-Powered Future - StockTitan

Predictive Oncology (POAI) Expected to Announce Earnings on Thursday - Defense World

Predictive Oncology to launch ChemoFx assay in Europe - MSN

Predictive Oncology receives financing from Renovaro Biosciences - Pennsylvania Business Report

Renovaro (RENB) and Predictive Oncology Partner for AI-Driven Drug Discovery: What’s Next for Cancer and HIV Treatments? - Insider Monkey

Renovaro provides financing to Predictive Oncology as both move to finalize definitive merger agreement - The Business Journals

MarketsMedicine Hat News - Financial Content

Milestone Merger Payment made with Predictive Oncology to Advance AI-Driven Biomarker Discovery and Precision Medicine in Cancer and Beyond: Renovaro, Inc. (NASDAQ: RENB) - The Globe and Mail

Milestone Merger Payment made with Predictive Oncology - openPR

Renovaro Completes First Milestone Payment To Finalize Definitive Agreement With Predictive Oncology - Marketscreener.com

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology - GlobeNewswire

Predictive Oncology Moves To Finalize Definitive Merger Agreement With Renovaro Biosciences - Marketscreener.com

Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences - The Manila Times

Renovaro completes first milestone payment for Predictive Oncology deal - TipRanks

Renovaro Biosciences Advances Financing for AI-Driven Integration and Strategic Expansion in Oncology through Acquisition of Predictive Oncology - Nasdaq

Can Renovaro's AI Oncology Merger Unlock Value From 150,000+ Tumor Samples? - StockTitan

Can This AI-Powered Oncology Merger Transform Cancer Treatment? First Financing Milestone Reached - StockTitan

Predictive Oncology Inc. (NASDAQ:POAI) Short Interest Down 26.1% in February - Defense World

Investors Eye Biotech Sector as Cancer Therapy Market Surges - KamloopsBCNow

Predictive Oncology announces registered direct offering; shares fall - MSN

Predictive Oncology Inc. Completes Registered Direct Offering of 363,336 Shares at $1.50 Per Share - Nasdaq

Predictive Oncology Closes Registered Direct Offering - The Bakersfield Californian

Can This $545K Capital Raise Give Predictive Oncology The Runway It Needs? - StockTitan

SEC Form 424B5 filed by Predictive Oncology Inc. - Quantisnow

Predictive Oncology prices 363,336 shares at $1.50 in registered direct offering - TipRanks

Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewswire

Inside Predictive Oncology's Latest Capital Raise: Key Details of the $545K Direct Offering - StockTitan

Predictive Oncology (NASDAQ:POAI) and Safe Pro Group Inc. Common Stock (NASDAQ:SPAI) Financial Review - Defense World

Predictive Oncology (POAI) Struggles AI-Driven Drug Repurposing Breakthrough - Insider Monkey

Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing - GlobeNewswire

What's Going On With Predictive Oncology Shares Tuesday?Predictive Oncology (NASDAQ:POAI) - Benzinga

Predictive Oncology reports positive results using AI for drug repurposing - TipRanks

Predictive Oncology Leverages AI To Identify Repurposed Drugs For Cancer Treatment Advancement - Nasdaq

AI Drug Discovery Milestone: Predictive Oncology Finds Cancer Treatment Gold in Abandoned Drugs - StockTitan

Predictive Oncology (NASDAQ:POAI) Stock Quotes, Forecast and News Summary - Benzinga

Certis Oncology Announces Issuance of U.S. Patent for Its Proprietary CertisAI Predictive Oncology Intelligence™ Platform - Business Wire

AI in Oncology Market worth $11.52 billion by 2030 - WICZ

Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput Drug Screening to Include Human Tumor Spheroids Using Automated Imaging and 3D Analysis - The Manila Times

Predictive Oncology Partners with Switzerland-Based Tecan - GlobeNewswire

Predictive Oncology Partners with Switzerland-Based Tecan Group Ltd. to Expand High-Throughput - The Bakersfield Californian

Finanzdaten der Predictive Oncology Inc-Aktie (POAI)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie POAI